18. October 2017
In the drug delivery area, versatile therapeutic systems intended to yield customized combinations of drugs, drug doses and release kinetics have drawn increasing attention, especially because of the advantages that personalized pharmaceutical treatments would offer.
14. August 2017
The potential for use of polymers in controlled drug delivery systems has been long recognized. Since their appearance in the literature, a wide range of degradable and non-degradable polymers have been demonstrated in drug delivery devices.
11. November 2016
DALLAS and DENVER (November 11, 2016) – Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present its EVA pharmaceutical material solutions at the 2016 AAPS Annual Meeting and Exposition November 13-17 at the Colorado Convention Center in Denver. Celanese will exhibit its pharmaceutical controlled release copolymer, VitalDose® ethylene vinyl acetate (EVA), at booth 1604. Celanese material experts will discuss the latest developments in pharmaceutical...
09. November 2016
Ethylene vinyl acetate (EVA) copolymer has a record of successfully serving the pharmaceutical industry as a controlled release excipient. EVA has shown excellent stability, processability and versatility in the controlled release of selected oral administered drugs via hot melt extrusion. In this literature review, you will discover: Information on EVA in oral drug delivery Many polymers have been used in oral formulations to provide various functions, including controlled release. EVA’s...
20. October 2016
ABSTRACT Ethylene vinyl acetate (EVA) has a long and successful history of innovation in medical packaging, medical devices, and pharmaceutical applications. In fact, EVA has been an innovative force in those applications for over 35 years and continues its innovation legacy through enablement of solutions in areas of ever increasing challenges. New solutions are required for continually improving patient healthcare. This paper will examine the evolutionary role of EVA innovation in diverse...
30. June 2016
VITALDOSE® EVA—AN EFFECTIVE DRUG DELIVERY TECHNOLOGY Our custom controlled release ethylene vinyl acetate, VitalDose® EVA, is improving pharmaceutical drug delivery applications around the world. VitalDose EVA is safe and dependable, and has performed effectively in controlled release applications for more than 20 years. Attend our technical presentation to see how our controlled release EVA is improving drug delivery technology. Join us at the 2016 Controlled Release Society (CRS) Annual...
12. May 2016
We want to learn more about your role in the pharmaceutical excipient selection process in your organization. The first 250 respondents who complete our short survey will receive a $20 Global Giving gift card. This card can be used to donate to a Global Giving charity project of your choice. Complete our short survey today and lend a hand to a charitable organization or project.* * E-card offer limited to the first 250 respondents who successfully complete and submit the survey (only one card...
20. July 2015
Celanese Presentation at 2015 CRS Annual Meeting & Exposition July 26-29, 2015 in Edinburgh, Scotland by Christian Schneider, R&D laboratory manager Sunday, July 26, 2015 – 1:25 pm to 1:30 pm More
18. June 2015
Formulation challenges are often associated with protein delivery vehicles, and controlled-release strategies that deliver medications locally are believed to offer some advantages. Most biologic formulations are made for a parenteral route of administration, but novel approaches, such as the use of microcellular foams, are being developed to enhance administration profiles and patient compliance. More